跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泰毕全 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dabigatran Etexilate Capsules
Approved
化学药品
Dabigatran Etexilate Capsules
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Aug 19, 2021
Approval ID
8BYtbYRyDtX
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8BYtbYRyDtX
Approval Number
国药准字HJ20170137
Generic Name
达比加群酯胶囊
Generic Name En
Dabigatran Etexilate Capsules
Trade Name
泰毕全
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
110mg
Reg Date
2021-08-19
Expired Date
2026-08-18
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 19, 2021
Approval ID
8BYtbYRyDtX
Type
化学药品
Back to NMPA Approvals